Patients needed for world-first COVID-19 booster vaccine study: we are sending texts to paients who are potentially eligible tomorrow. The text will say "We are asking patients who had their Covid vaccine early in the program to participate in a clinical trial for a booster study. For more information or to participate please click Hedge End Medical Centre" - this is not a scam text!

More information below.

Thousands of volunteers are to receive a “booster” COVID-19 vaccine in a new clinical trial led by University Hospital Southampton NHS Foundation Trust (UHS).

The Cov-Boost trial, led by Professor Saul Faust, Chief Investigator and Director of National Institute for Health Research (NIHR) Southampton Clinical Research Facility, is studying the use of seven different COVID-19 vaccines when given as a third dose.

It is the first in the world to provide vital date on the impact of a third dose on patients’ immune responses.

The trial is backed by £19.3m of funding from the Government’s Vaccine Taskforce and running at 17 trial sites nationwide including University Hospital Southampton and the Portsmouth Research Hub, run by Portsmouth Hospitals University NHS Trust.

The trial has received ethics approval from the NHS Research Ethics Committee, as well as approval from the Medicines and Healthcare products Regulatory Agency.

Participants will be adults aged 30 years or older and include those immunised early on in the vaccination programme, such as adults aged 75 and over or health and care workers.

Volunteers are being recruited through the NHS COVID-19 Vaccine Research Registry and the study’s website.

Published: Jun 4, 2021